Stocks Telegraph

APLS Stock Price History and Quote Analysis: Insights for Investors

NASDAQ:APLS

Apellis Pharmaceuticals, Inc.

$27.14
0.47+1.76%
At Close 4:00 PM
$27.20
0.06+0.22%
After-Market 07:55 PM
70.23
BESG ScoreESG Rating

APLS FINANCIAL STATEMENTS

An instrumental part of fundamental analysis is measuring key indicators of an asset, which are the factors that can influence its value and price. However, sometimes investors show more interest in financial statements with other factors to determine whether investing in that company is the right decision. Financial statements of a company include:

  • Balance Sheet
  • Income Statement
  • Cash Flow Statement

APLS Income Statement


A company's income statement helps investors and business owners determine whether the company is profitable or losing money. Profitability is a key factor investors consider before investing in a stock. Income statements provide them with information about a company's profitability over time. The statement also enables them to observe trends in company spending and earnings since it breaks down individual costs and revenues. Income statements also provide details on where a company's money is going when it isn't profitable or its profits fluctuate.

Date2024-06-302024-03-312023-12-312023-09-302023-06-30
reported currencyUSDUSDUSDUSDUSD
calendar year20242024202320232023
periodQ2Q1Q4Q3Q2
revenue199.685M172.325M146.377M99.182M94.969M
cost of revenue23.549M20.653M19.912M22.41M8.379M
gross profit176.136M151.672M126.465M76.772M86.59M
gross profit ratio0.8820.880.8640.7740.912
research and development expenses77.947M84.701M69.282M79.421M95.658M
general and administrative expenses00141.701M145.648M111.373M
selling and marketing expenses00000
selling general and administrative expenses127.632M129.061M141.701M145.648M111.373M
other expenses24.00K-499.00K219.00K-603.00K-63.00K
operating expenses205.579M213.762M210.983M225.069M207.031M
cost and expenses229.128M234.415M230.895M247.479M215.41M
interest income3.184M3.303M4.548M4.989M6.002M
interest expense9.359M6.967M7.402M-7.31M7.341M
depreciation and amortization449.00K444.00K490.00K405.00K410.00K
ebitda-28.994M-61.646M-84.028M-148.297M-114.502M
ebitda ratio-0.145-0.358-0.574-1.495-1.206
operating income-29.443M-62.09M-84.518M-148.297M-120.441M
operating income ratio-0.147-0.36-0.577-1.495-1.268
total other income expenses net-8.10M-4.163M-2.635M8.293M-63.00K
income before tax-37.543M-66.253M-87.153M-140.004M-121.843M
income before tax ratio-0.188-0.384-0.595-1.412-1.283
income tax expense114.00K170.00K1.423M233.00K194.00K
net income-37.657M-66.423M-88.576M-140.237M-122.037M
net income ratio-0.189-0.385-0.605-1.414-1.285
eps-0.30-0.54-0.73-1.17-1.02
eps diluted-0.30-0.54-0.73-1.17-1.02
weighted average shs out123.904M122.957M121.232M120.292M119.316M
weighted average shs out dil123.904M122.957M121.232M120.292M119.316M
Graph

APLS Balance Sheet


Balance sheet summarizes a company's financials and can be used as a basis by investors to determine the value of a company. It shows the value of the stock, as well as the assets and liabilities of the company. A company's balance sheet displays how its assets are put to use and how those assets are financed, based on the liabilities section. Both investors and analysts analyze a company's balance sheet to determine how it allocates its resources.

Date2024-06-302024-03-312023-12-312023-09-302023-06-30
reported currencyUSDUSDUSDUSDUSD
calendar year20242024202320232023
periodQ2Q1Q4Q3Q2
cash and cash equivalents361.426M327.026M352.299M452.414M616.259M
short term investments7.954M7.62M013.116M9.423M
cash and short term investments361.426M327.026M352.299M452.414M616.259M
net receivables308.851M267.837M206.442M186.989M110.913M
inventory152.772M161.283M146.362M98.545M103.216M
other current assets36.925M55.282M61.228M13.116M26.809M
total current assets859.974M811.428M766.331M796.767M892.686M
property plant equipment net20.157M19.189M21.09M20.274M22.065M
goodwill00000
intangible assets00000
goodwill and intangible assets00000
long term investments00000
tax assets00000
other non current assets24.351M1.313M1.309M1.175M827.00K
total non current assets44.508M20.502M22.399M21.449M22.892M
other assets1.001.00000
total assets904.482M831.93M788.73M818.216M915.578M
account payables38.27M26.788M37.516M18.192M27.50M
short term debt6.214M83.544M6.441M5.739M5.852M
tax payables00000
deferred revenue1.903M3.56M0117.089M97.716M
other current liabilities122.781M101.399M203.636M44.61M43.769M
total current liabilities169.168M215.291M247.593M185.63M174.837M
long term debt457.211M337.535M93.033M103.837M104.949M
deferred revenue non current00000
deferred tax liabilities non current00000
other non current liabilities13.776M12.428M253.583M296.478M290.389M
total non current liabilities470.987M349.963M346.616M400.315M395.338M
other liabilities1.000000
capital lease obligations11.085M9.77M11.454M16.619M17.918M
total liabilities640.155M565.254M594.209M585.945M570.175M
preferred stock00000
common stock12.00K12.00K12.00K12.00K12.00K
retained earnings-2.942B-2.904B-2.837B-2.749B-2.609B
accumulated other comprehensive income loss-3.362M-3.525M-3.542M-1.065M-796.00K
other total stockholders equity3.209B3.174B3.036B2.982B2.955B
total stockholders equity264.327M266.676M194.521M232.271M345.403M
total equity264.327M266.676M194.521M232.271M345.403M
total liabilities and stockholders equity904.482M831.93M788.73M818.216M915.578M
minority interest00000
total investments7.954M7.62M013.116M9.423M
total debt474.51M430.849M110.928M109.576M110.801M
net debt113.084M103.823M-241.371M-342.838M-505.458M
Graph

APLS Cash Flow


A cash flow statement is regarded as a valuable indicator of profitability and the long-term outlook for a company. It assists the company in evaluating whether it has sufficient funds to cover its expenses. Essentially, a cash flow statement represents an organization's financial health. The cash flow statement, which measures the business's ability to operate in the short as well as long term, is broken down into operating, investing, and financing activities.

Date2024-06-302024-03-312023-12-312023-09-302023-06-30
reported currencyUSDUSDUSDUSDUSD
calendar year20242024202320232023
periodQ2Q1Q4Q3Q2
deferred income tax00-133.00K133.00K0
stock based compensation29.99M30.349M26.219M21.625M29.278M
change in working capital-6.178M-103.495M-42.556M-57.499M-64.325M
accounts receivables-36.575M-61.415M-37.173M-58.356M-79.408M
inventory-14.51M-14.921M-47.816M4.671M-17.646M
accounts payables11.489M-10.73M19.62M-9.601M-3.995M
other working capital33.418M-16.429M22.813M5.787M36.724M
other non cash items75.541M124.445M6.681M6.488M6.519M
net cash provided by operating activities-8.339M-132.983M-97.875M-169.085M-150.155M
investments in property plant and equipment-90.00K-293.00K-95.00K-47.00K-372.00K
acquisitions net0099.00K00
purchases of investments00000
sales maturities of investments00000
other investing activites00000
net cash used for investing activites-90.00K-293.00K4.00K-47.00K-372.00K
debt repayment-37.332M-98.763M-24.50M0-24.50M
common stock issued5.155M9.477M27.089M5.757M26.088M
common stock repurchased0-28.00K11.038M-11.00K-28.00K
dividends paid00-1.56M0-1.56M
other financing activites-229.359M-28.00K-15.98M-11.00K1.56M
net cash used provided by financing activities42.487M108.212M-3.913M5.746M1.56M
effect of forex changes on cash342.00K-209.00K584.00K-458.00K-47.00K
net change in cash34.40M-25.273M-101.201M-163.844M-149.014M
cash at end of period361.426M327.026M352.299M453.50M617.344M
cash at beginning of period327.026M352.299M453.50M617.344M766.358M
operating cashflow-8.339M-132.983M-97.875M-169.085M-150.155M
capital expenditure-90.00K-293.00K-95.00K-47.00K-372.00K
free cash flow-8.429M-133.276M-97.97M-169.132M-150.527M
Graph

Frequently Asked Questions

How did Apellis Pharmaceuticals, Inc. do last quarter? What was its Total Revenue and Cost of Revenue?

A company's Total Revenue reveals how much money it generates before any expenses or deductions are made. As a result, this metric informs investors/stakeholders how much money the business makes. Tracking and understanding it is essential for evaluating a company's growth. As opposed to revenue, Cost of Revenue is any expenses a business incur to generate revenue. There can be high revenue in a business, but if the costs are high, it won't make a profit and will go out of business when money runs out. Therefore, APLS generated $199.69M in revenue last quarter, while its costs came in at $23.55M.

Last quarter, how much Gross Profit did Apellis Pharmaceuticals, Inc. report?

A business's Gross Profit is a key indicator of its profitability and financial performance. In other words, it reflects how efficiently a business uses labor, raw materials, and other resources. Apellis Pharmaceuticals, Inc. reported a $176.14M Gross Profit for the quarter ended Jun 30, 2024.

Have APLS's Total Operating Expenses and Operating Income been favorable recently?

Operational Expenses represent the costs a company must incur to generate revenue, which is the ultimate goal of a business, whereas Operating Income shows the revenue left after operational direct and indirect costs have been deducted. APLS incurred $205.58M worth of Operating Expenses, while it generated -$29.44M worth of Operating Income.

How much Net Income has APLS posted recently?

The Net Income of a company is one of the factors investors consider when investing in the company. According to recent earnings report from Apellis Pharmaceuticals, Inc., the company generated -$37.66M in Net Income. When a company has a history of consistent net income, investors are more likely to invest in it since they know they will get a return.

At the end of the last quarter, how much Cash and Equivalents did Apellis Pharmaceuticals, Inc. have?

The amount of Cash and Cash Equivalents is an effective indicator of the financial strength and well-being of a company. An excess cash situation occurs when a company has more cash and cash equivalents than it needs for operating activities. The amount of Cash and Cash Equivalents available to Apellis Pharmaceuticals, Inc. as of the end of the last quarter was $361.43M.

What are APLS's Total Net Receivables for the last quarter?

Total Net Receivables are a company's outstanding debts to its customers. Therefore, it refers to the amount that a company expects to collect from its customers. The higher a company's net receivables are, the more confident it is that it can collect money from its debtors. As of the end of the last quarter, APLS had Total Net Receivables of $308.85M.

In terms of Total Assets and Current Assets, where did Apellis Pharmaceuticals, Inc. stand at?

An asset with an economic value within a year is considered a current asset. Total assets, however, also include long-term fixed assets, intangible assets, and other non-current assets. The current Assets of APLS were $859.97M, while the Total Assets stand at $904.48M.

As of the last quarter, how much Total Debt did Apellis Pharmaceuticals, Inc. have?

The total debt of a business refers to how much it borrows. A company's current and long-term liabilities are added together to calculate its Total Debt. A debt ratio may be taken into account on a balance sheet by financial lenders, investors, and business leaders when making informed decisions about future loans or investments. The total amount of APLS's debt was $474.51M at the end of the last quarter.

What were APLS's Total Liabilities during the last reported quarter?

A company's total liabilities are the sum of all debts it is liable for, including any off-balance shee liabilities it may incur. This can be calculated by adding up all short-term and long-term liabilities. In its last quarter, APLS reported total liabilities of $640.16M.

How much did APLS's Working Capital change over the last quarter?

Working Capital Change for APLS was -$6.18M over the last quarter. Working Capital Change refers to the difference between net working capital amounts at the end of one accounting period and the end of another. It tells investors/stakeholders how much the company's cash flow will differ from its Net Income (i.e., after-tax profits). More powerful companies often have positive Change in Working Capital numbers as they have increased control over collecting cash from customers and delaying payments to suppliers.

APLS generated how much cash from operating activities?

An operating cash flow statement usually contains cash from operating activities in the first section. An organization's cash from operating activities refers to the money it takes in and takes out as a result of its regular business operations. APLS generated -$8.34M of Cash from Operating Activities during its recently reported quarter.

What was APLS's latest reported Net Change in Cash?

An increase or decrease in cash and cash equivalent balances within a specified period is considered the net change in cash in a cash flow statement. Furthermore, it takes into account cash changes as a result of investments, financing, and operating activities. APLS reported a $34.40M Net Change in Cash in the most recent quarter.

logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2024 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph